|
Ceravision steps up legal action against Luxim to recover IP
- Litigation against Luxim to go to full trial in London High Court and US District Court
- Ceravision takes a 'zero tolerance' approach to protecting its IP
- Luxim patent remains suspended in Europe
- Pending actions relate to non-essential part of Ceravision's IP; no impact on revolutionary
Continuum® 2.4 and Ecolumination™ technology ranges
Bletchley Park Science and Innovation Centre, UK
4 April 2008
It has been announced today that litigation against Luxim Corporation's core patents by Ceravision
Limited will go to a full trial in both the United States and the United Kingdom.
Both disputes relate to technologies developed during a joint venture partnership between
Ceravision Limited and Digital Reflection Inc (DRI) in 1999. Ceravision partnered with DRI to bring
its ceramics expertise to DRI's light source technologies. Ceravision's first patent filing in this field
(now granted US patent number 6,666,739) dates back to December 1999, many months before the
creation of Luxim.
As described in Ceravision's High Court pleadings, Luxim's founders signed a consultancy agreement
in April 2000 to provide engineering support to DRI. As further detailed in its US and UK filings, after
being paid in excess of $230,000 by DRI during a four-month period, and having information
disclosed to them under a Non Disclosure Agreement, the Luxim founders filed the disputed patent
application covering aspects of the work previously conceived of by DRI.
Ceravision purchased DRI's assets in 2004 in order to acquire full legal title to the technology that it
had jointly developed in conjunction with DRI and to complement its existing patented intellectual
property.
Tim Reynolds, CEO of Ceravision said:
"The origins of Luxim's core patent filings have always been disputed and we will continue to do so
until the grave concerns that we hold have been fully tested. We expect that a full trial before both
the High Court in London, and the US District Court will properly examine for the very first time the
fundamental matters affecting the integrity of Luxim's core intellectual property. Pending the
outcome of the Entitlement proceedings, Luxim's core international patent application will remain
suspended in Europe. We would like to take this opportunity to correct any misapprehension that
either of the patent proceedings has been fully determined or that Luxim has prevailed, or ultimately
will prevail, in this dispute.
The enforcement of our intellectual property rights is of paramount importance to Ceravision and we
look forward to addressing these issues before the relevant courts and are delighted that this matter
is now in the public domain."
Media contacts
| Tim Williamson | Sarah West |
| Brunswick Group LLP | Brunswick Group LLP |
| +44 207 404 5959 | +44 207 404 5959 |
About Ceravision
Ceravision Ltd is the inventor of the Continuum® 2.4 and Ecolumination™ technology ranges and
the holder of all the related intellectual property, patented worldwide. A research and licensing
company with full sub contract manufacturing capabilities; Ceravision is based in Bletchley Park,
UK.
Ceravision is backed by a number of large investors including Saad Investments and ASA
Consultants.
Ceravision is bringing several major new lighting technologies to market which give long life,
excellent stable spectrum, energy efficiency, environmental friendliness, low cost, high brightness
and small size.
|